Why Agios Pharmaceuticals Inc. Shares Popped

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of Agios Pharmaceuticals  (NASDAQ: AGIO  ) are up nearly 10% today after the company before the opening bell announced the hiring of a well-regarded new chief medical officer.

So what: Agios brought Dr. Chris Bowden on board to oversee the company's clinical development and regulatory initiatives. Bowden has nearly two decades of experience in clinical drug development, most notably as vice president of oncology product development for Roche's Genentech subsidiary. His team developed several notable cancer treatments at Genentech, including Zelboraf, Tarceva, and Erivedge, according to Agios' press release.

Now what: Genentech's cancer treatments are among the world's best-sellers, and Bowden's developments have been among his former employer's most promising new drugs -- Zelboraf was named the Best New Drug of 2012 at the year's Scrip Awards. In 2008, the last year for which Genentech provides drug revenue breakdowns, Tarceva generated over $450 million in revenue. 

If Bowden can develop even one drug on the same scale as his previous successes with Genentech, it stands to reason that Agios could find far more sales than it has today. However, this pop is still nothing more than a bet on future discoveries, and Bowden still has a long road ahead of him at Agios before he can replicate his Genentech successes.

Invest in the next wave of health care innovation
The Economist compares this disruptive invention to the steam engine and the printing press. Business Insider says it's "the next trillion dollar industry." And the technology behind is poised to set off one of the most remarkable health care revolutions in decades. The Motley Fool's exclusive research presentation dives into this technology's true potential, and its ability to make life-changing medical solutions never thought possible. To learn how you can invest in this unbelievable new technology, click here now to see our free report.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2957817, ~/Articles/ArticleHandler.aspx, 8/29/2015 2:07:44 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Alex Planes

Alex Planes specializes in the deep analysis of tech, energy, and retail companies, with a particular focus on the ways new or proposed technologies can (and will) shape the future. He is also a dedicated student of financial and business history, often drawing on major events from the past to help readers better understand what's happening today and what might happen tomorrow.

Connect with Alex on LinkedIn or Twitter for more news and insight:

View Alex Planes's profile on LinkedIn

Today's Market

updated 4 hours ago Sponsored by:
DOW 16,643.01 -11.76 -0.07%
S&P 500 1,988.87 1.21 0.06%
NASD 4,828.33 15.62 0.32%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

8/28/2015 4:00 PM
AGIO $90.69 Up +0.67 +0.74%